W20 Buys Patient Data Firms Swoop and IPM.ai

Healthcare marcoms specialist W20 has acquired machine learning and real-world data specialists Swoop and IPM.ai, also focused on the sector. Terms of the deals have not been disclosed.

Swoop identifies patient segments through a database of more than 300 million anonymised patients and 65 billion anonymous consumer interactions, to help clients with targeting of healthcare engagement and make patients participants in their 'treatment journey'. IPM.ai uncovers details of the ideal patient, for use in the research, development, and commercialization of therapies in under-defined patient populations. Uses span a range from market assessment and treatment journey mapping to healthcare provider discovery and identification of key opinion leaders.

As part of the takeover deal, Swoop and IPM.ai founder Ron Elwell (pictured), and the firms' existing leadership team, technologists, data scientists, life sciences experts and digital marketing professionals, will continue in their roles. Jim Weiss, founder and CEO of W2O, comments: 'In the increasingly digital post-pandemic era, we need to help our clients move faster and with more precision and efficiency to conduct clinical trials, launch new products, maximize peak revenue opportunities, and successfully navigate product lifecycles. The acquisition of Swoop and IPM.ai enables this game-changing approach - with the goal of improving healthcare from bench to bedside'.

Web sites: www.w2ogroup.com , www.swoop.com and www.ipm.ai .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.